BCL2L1 and prostate cancer: On the other hand, in prostate cancer, a factor that binds to inducer of short transcripts protein 1 (FBI-1) is shown to interact with Sam68, and control Sam68-mediated alternative splicing of BCL-X through histone deacetylases, suggesting the importance of acetylation for Sam68 activity [109].